Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Jones

Showing results (521-530 of 586) with videos related to

Pageof 59
Sort By:
The Veterinary Record|October 27, 2018
Effectiveness of badger cullsIain McGill, Andre Menache, Richard Saunders, et al.
Vaccine|August 22, 2018
Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study in healthy adultsJessica A Chichester, Brian J Green, R Mark Jones, et al.
Human Vaccines & Immunotherapeutics|April 24, 2015
Expression, purification, and characterization of the Necator americanus aspartic protease-1 (Na-APR-1 (M74)) antigen, a component of the bivalent human hookworm vaccineChristopher A Seid, Elena Curti, R Mark Jones, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 9, 2024
Erratum to 'TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylate' [Clin Microbiol Infect (30) (2024) 743-754]María Patricia Hernández-Mitre, Susan C Morpeth, Balasubramanian Venkatesh, et al.
Annals of Hematology|February 4, 2018
Efficacy and safety of ruxolitinib after and versus interferon use in the RESPONSE studiesJean-Jacques Kiladjian, Paola Guglielmelli, Martin Griesshammer, et al.
BMJ Open|March 17, 2021
Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic reviewRay Moynihan, Sharon Sanders, Zoe A Michaleff, et al.
Vaccine|December 30, 2022
Engineering of a plant-produced virus-like particle to improve the display of the Plasmodium falciparum Pfs25 antigen and transmission-blocking activity of the vaccine candidateStephen Tottey, Yoko Shoji, R Mark Jones, et al.
International Journal of Radiation Oncology, Biology, Physics|June 22, 2016
Trigeminal Neuralgia Treated With Stereotactic Radiosurgery: The Effect of Dose Escalation on Pain Control and Treatment OutcomesRupesh Kotecha, Ritesh Kotecha, Sujith Modugula, et al.
Cancer Research Communications|December 20, 2023
Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I StudyPamela Munster, Nicholas Iannotti, Daniel C Cho, et al.
Human Molecular Genetics|September 15, 2005
Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cellsTariq Enver, Shamit Soneji, Chirag Joshi, et al.
Pageof 59

Showing results (521-530 of 586) with videos related to

Sort By:
Pageof 59
The Veterinary Record|October 27, 2018
Effectiveness of badger cullsIain McGill, Andre Menache, Richard Saunders, et al.
Vaccine|August 22, 2018
Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study in healthy adultsJessica A Chichester, Brian J Green, R Mark Jones, et al.
Human Vaccines & Immunotherapeutics|April 24, 2015
Expression, purification, and characterization of the Necator americanus aspartic protease-1 (Na-APR-1 (M74)) antigen, a component of the bivalent human hookworm vaccineChristopher A Seid, Elena Curti, R Mark Jones, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 9, 2024
Erratum to 'TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylate' [Clin Microbiol Infect (30) (2024) 743-754]María Patricia Hernández-Mitre, Susan C Morpeth, Balasubramanian Venkatesh, et al.
Annals of Hematology|February 4, 2018
Efficacy and safety of ruxolitinib after and versus interferon use in the RESPONSE studiesJean-Jacques Kiladjian, Paola Guglielmelli, Martin Griesshammer, et al.
BMJ Open|March 17, 2021
Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic reviewRay Moynihan, Sharon Sanders, Zoe A Michaleff, et al.
Vaccine|December 30, 2022
Engineering of a plant-produced virus-like particle to improve the display of the Plasmodium falciparum Pfs25 antigen and transmission-blocking activity of the vaccine candidateStephen Tottey, Yoko Shoji, R Mark Jones, et al.
International Journal of Radiation Oncology, Biology, Physics|June 22, 2016
Trigeminal Neuralgia Treated With Stereotactic Radiosurgery: The Effect of Dose Escalation on Pain Control and Treatment OutcomesRupesh Kotecha, Ritesh Kotecha, Sujith Modugula, et al.
Cancer Research Communications|December 20, 2023
Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I StudyPamela Munster, Nicholas Iannotti, Daniel C Cho, et al.
Human Molecular Genetics|September 15, 2005
Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cellsTariq Enver, Shamit Soneji, Chirag Joshi, et al.
Pageof 59